Dr. Jacques Farhi
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Virginia School of Medicine (2017)
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 945
Licensed in Texas since 2021, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Medical school: University of Virginia School of Medicine
- 2017Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
FL license ME159973 · TX license T4630 (first issued 2021; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Hospital Pensacola, FL
- Baptist Hospital Pensacola, FL
- Gulf Breeze Hospital Gulf Breeze, FL
- Sacred Heart Hospital on The Emerald Coast Miramar Beach, FL
- HCA Florida West Hospital Pensacola, FL
Medical groups
- Florida Cancer Specialists and Research Institute, LLC (498 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 945
- Services billed
- 24,914
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Identification of organisms by genetic analysis, amplified probe technique | 288 | 23 |
| Automated urinalysis test | 89 | 79 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 72 | 23 |
| Established patient office or other outpatient visit, 30-39 minutes | 64 | 59 |
| New patient office or other outpatient visit, 45-59 minutes | 52 | 52 |
| Detection test for candida species (yeast), amplified probe technique | 48 | 23 |
| Detection test by nucleic acid for organism, amplified probe technique | 48 | 23 |
| Established patient office or other outpatient visit, 20-29 minutes | 44 | 40 |
| Ultrasound measurement of bladder capacity after voiding | 37 | 34 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 36 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Pensacola, FL | 449 |
| Finasteride Other prescribers in Pensacola, FL | 272 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Pensacola, FL | 142 |
| Oxycodone Hcl Other prescribers in Pensacola, FL | 82 |
| Dutasteride Other prescribers in Pensacola, FL | 59 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Pensacola, FL | 58 |
| Xtandi (enzalutamide) | 47 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Pensacola, FL | 42 |
| Testosterone Cypionate Other prescribers in Pensacola, FL | 41 |
| Gemtesa (vibegron) Other prescribers in Pensacola, FL | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 36 payments worth $892 in total to this clinician.
| Astellas Pharma US Inc | $182 |
|---|---|
| Sumitomo Pharma America, Inc. | $142 |
| Abc Home Medical Supply, Inc. | $129 |
| Janssen Biotech, Inc. | $99.95 |
| Procept Biorobotics Corporation | $88.24 |
| Novartis Pharmaceuticals Corporation | $38.65 |
| AbbVie Inc. | $36.57 |
| Urogen Pharma, Inc. | $36.06 |
| Food and Beverage | $715 |
|---|---|
| Education | $178 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Astellas Pharma US Inc May 19, 2025 | Education in-kind | $99.00 |
| Astellas Pharma US Inc May 19, 2025 | Education in-kind | $68.00 |
| Travere Therapeutics, Inc. Jul 30, 2025 | Education Thiola · Kidney Stones · in-kind | $3.01 |
| Travere Therapeutics, Inc. Jul 30, 2025 | Education Thiola · Kidney Stones · in-kind | $2.55 |
| Travere Therapeutics, Inc. Jul 30, 2025 | Education Thiola · Kidney Stones · in-kind | $1.97 |
| Travere Therapeutics, Inc. Jul 30, 2025 | Education Thiola · Kidney Stones · in-kind | $1.92 |
| Travere Therapeutics, Inc. Jul 30, 2025 | Education Thiola · Kidney Stones · in-kind | $1.10 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.